There are 2934 resources available
Yes
Presenter: Rebecca Dent
Session: Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)?
Resources:
Slides
Webcast
No
Presenter: Hope Rugo
Session: Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)?
Resources:
Slides
Webcast
Presentation by expert
Presenter: Philip Poortmans
Session: Partial breast radiation therapy: Which patients, when, and with what technique?
Resources:
Slides
Webcast
Potential clinical utility of analysing circulating tumor DNA for CRC
Presenter: Clara Montagut Viladot
Session: The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC)
Resources:
Slides
1170 - Is Immuno-Oncology Therapy Effective in Hypermutator Glioblastomas with Somatic or Germline mutations ?
Presenter: Carlos Kamiya-Matsuoka
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Welcome, introductions and agenda
Presenter: Ian Chau
Session: Bristol-Myers Squibb - Understanding the Emerging Role of I-O in GI Cancers
Resources:
Webcast
I-O Studies in CRC: Patient populations of today and tomorrow
Presenter: Miriam Koopman
Session: Bristol-Myers Squibb - Understanding the Emerging Role of I-O in GI Cancers
Resources:
Webcast
Evolving treatment options and the potential of I-O for patients with HCC
Presenter: Robin Katie Kelley
Session: Bristol-Myers Squibb - Understanding the Emerging Role of I-O in GI Cancers
Resources:
Webcast
Panel discussion and audience Q&A
Presenter: Ian Chau
Session: Bristol-Myers Squibb - Understanding the Emerging Role of I-O in GI Cancers
Resources:
Webcast
Clinical Data with I-O in esophageal cancer
Presenter: Ian Chau
Session: Bristol-Myers Squibb - Understanding the Emerging Role of I-O in GI Cancers
Resources:
Webcast